Highlights of the exposition!It's been another busy day here in Boston! We've explored the exposition, tracked down the best goodies and met lots and lots of fantastic members - thanks for dropping by.
Talk highlights included a stream on treating rare diseases using new chemical advances, featuring Xueqing Wang (Pharmacyclics, CA, USA) discussing the discovery of CFTR correctors for the treatment of cystic fibrosis, while another stream highlighted novel treatments to combat chronic pain and confront the opioid epidemic.
Great talks today at #ACSBoston on finding new hits (and even leads!) for #ChronicPain in order to confront #opioidepidemic. Remarkable insights from both fronts - GPCRs and ion channels by Dr Steven McKerrall, Benjamin Milgram and Prof Laura Bohm.Another highlight of the day was the watching The Tetrahedron Prize being awarded to Laura Kiessling (MIT, MA, USA), who then presented her fascinating research on carbohydrates as microbial IDs.
Great talk by @LoriFerrins about @IntlYoungerChem! #IYCN #ACSBoston pic.twitter.com/psoCS9fesO
|Video of the day|
|Jasmine Harris, Editor (London, UK)|
|Picture of the Day||Tomorrow's key talk|
|Emerging Trends in Target Identification|
|We got our photo taken with Professor Molenium and Meg-A-Mole!||Room 210A, Boston Convention and Exhibition Center|
|Today's news highlights|
|Anticancer strategies: can we prevent severe oral mucositis?||Tackling mosquito-borne diseases with next-generation insect repellents|
|Research presented at the 265th National Meeting and Exposition of the American Chemical Society (19–23 August 2018) suggests a new drug could prevent a common debilitating side effect of cancer treatment.||At the 256th ACS National Meeting and Exhibition (19–23 August 2018),
Iowa State University researchers report a new class of insect
repellents that could help combat mosquito-borne diseases.|